City Hospital is a major hospital located in Birmingham, England, operated by the Sandwell and West Birmingham Hospitals NHS Trust. It provides an extensive range of general and specialist hospital services. It is located in the Winson Green area of the west of the city.

During the past decade, City Hospital - Birmingham conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City Hospital - Birmingham" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Institute of Cancer Research, United Kingdom" with 4 trials sponsored, "Cancer Research Campaign Clinical Trials Centre" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City Hospital - Birmingham" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Baim Institute for Clinical Research" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "City Hospital - Birmingham" are "Breast Cancer" (9 trials), "Ovarian Cancer" (4 trials), "Lymphoma" (3 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "City Hospital - Birmingham" in a lesser frequency.

Most popular intervention types in "City Hospital - Birmingham" are "Drug" (26 trials), "Procedure" (9 trials), "Biological" (4 trials), "Other" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "adjuvant therapy" (4 trials), "Placebo" (3 trials), "epirubicin hydrochloride" (3 trials) and "CHOP regimen" (2 trials). Other intervention names were less common.

The vast majority of trials in "City Hospital - Birmingham" are 24 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "City Hospital - Birmingham". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in City Hospital - Birmingham, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in City Hospital - Birmingham, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".